Smith S W, Stewart H F, Jenkins D P
Ultrasonics. 1985 Jan;23(1):31-40. doi: 10.1016/0041-624x(85)90008-3.
Determination of in situ ultrasound exposures in experimental animals and patients is necessary to assess any potential hazard of ultrasound implied by reported biological effects in animals. A layered model was used to calculate total attenuation of ultrasound pulses as they passed through tissue layers to an organ site, thus enabling calculation of in situ intensities from free-field transducer emissions. The model assumes plane homogeneous layers of tissue of known thickness, attenuation and acoustic impedance. Calculations based on the model, compared with in situ measurements in a human cadaver specimen, were accurate to within approximately +/- 3 dB. We then calculated in situ clinical exposures using published obstetric B-scans. Total attenuation to the fetus averaged approximately 11 dB at 3.5 MHz.
测定实验动物和患者的原位超声暴露对于评估动物报告的生物学效应所暗示的超声任何潜在危害是必要的。使用分层模型计算超声脉冲穿过组织层到达器官部位时的总衰减,从而能够根据自由场换能器发射计算原位强度。该模型假设组织为具有已知厚度、衰减和声阻抗的平面均匀层。基于该模型的计算与人体尸体标本的原位测量相比,精确到大约±3dB以内。然后,我们使用已发表的产科B超扫描计算原位临床暴露。在3.5MHz时,到达胎儿的总衰减平均约为11dB。